Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 16:13:1107703.
doi: 10.3389/fonc.2023.1107703. eCollection 2023.

Particle radiotherapy for breast cancer

Hanguang Ruan  1   2 , Masahiko Okamoto  1   2 , Tatsuya Ohno  1   2 , Yang Li  3 , Yuan Zhou  1   2
Affiliations
Review

Particle radiotherapy for breast cancer

Hanguang Ruan et al. Front Oncol. .

Abstract

Breast cancer is the most common malignant tumor in female patients. Along with surgery, radiotherapy is one of the most commonly prescribed treatments for breast cancer. Over the past few decades, breast cancer radiotherapy technology has significantly improved. Nevertheless, related posttherapy complications should not be overlooked. Common complications include dose-related coronary toxicity, radiation pneumonia, and the risk of second primary cancer of the contralateral breast. Particle radiotherapy with protons or carbon ions is widely attracting interest as a potential competitor to conventional photon radiotherapy because of its superior physical and biological characteristics. This article summarizes the results of clinical research on proton and carbon-ion radiotherapy for treating breast cancer.

Keywords: breast cancer; carbon ion; particle; photon; proton; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic diagram of depth-dose distributions of different radiation modalities [LUKAS SCHAUB et al. (18)]
Figure 2
Figure 2
The number of patients with protons and carbon ions beams (collected by the PTCOG, end of 2020).
Figure 3
Figure 3
Computed tomography (CT) dose color wash from an IMRT plan (A) and pencil-beam scanning PT plan (B) [Mutter et al. (13)].
Figure 4
Figure 4
Portal setting and dose distribution of the patients [Karasawa et al. (39)]. Arrow means the deliver beams direction.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2021) 71(3):209–49. doi: 10.3322/caac.21660 - DOI - PubMed
    1. Overgaard M, Nielsen HM, Tramm T, Højris I, Grantzau TL, Alsner J, et al. . Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the danish breast cancer cooperative group DBCG 82bc trial. Radiother Oncol (2022) 170:4–13. doi: 10.1016/j.radonc.2022.03.008 - DOI - PubMed
    1. Meattini I, Becherini C, Boersma L, Kaidar-Person O, Marta GN, Montero A, et al. . European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol (2022) 23(1):e21–31. doi: 10.1016/S1470-2045(21)00539-8 - DOI - PubMed
    1. Hennequin C, Belkacémi Y, Bourgier C, Cowen D, Cutuli B, Fourquet A, et al. . Radiotherapy of breast cancer. Cancer Radiother (2022) 26(1-2):221–30. doi: 10.1016/j.canrad.2021.11.013 - DOI - PubMed
    1. Xu FF, Cao L, Xu C, Cai G, Wang SB, Qi WX, et al. . Practical model to optimize the strategy of adjuvant postmastectomy radiotherapy in T1-2N1 breast cancer with modern systemic therapy. Front Oncol (2022) 12:789198. doi: 10.3389/fonc.2022.789198 - DOI - PMC - PubMed